Medicinal chemistry – Page 60
- 
      
        
      
      
     - 
      News
US drug development costs surge
The price of developing new prescription drugs in the US has increased 145% since 2003, Tufts data shows
 - 
      
        
      
      
     - 
      News
Mouse model to assess chemical exposure
Outbred mice can be used predict how human’s will respond to harmful chemicals with examination of chromosomal damage
 - 
      
        
      
      PodcastPsilocybin & Mescaline
Simon Cotton explores our hallucinogenic horizons with psilocybin and mescaline
 - 
      Business
Labcorp to buy Covance and enter contract research
Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal’s value
 - 
      Research
Aptamers and gold nanoparticles whisked up to spot influenza
Gold-coated flu viruses sink in visual bioassay
 - 
      
        
      
      ResearchSleeping sickness fly trap in a nutshell
Isomerising-cross metathesis could help curb tropical disease by converting cashew byproduct into sustainable pest control
 - 
      
        
      
      PodcastChemistry World podcast - November 2014
We speak to Eric Betzig about his Nobel prize-winning research, and find out how thermoelectric materials can be made more efficient
 - 
      
        
      
      ResearchReview finds nanosafety is no small issue
Audit of safety studies reveals shortcomings that distort our understanding of nanomaterial toxicity
 - 
      
        
      
      NewsUS agency fast-tracks Ebola vaccine development
Health and Human Services invests almost $6 million to ready an Ebola vaccine candidate for clinical trials, meanwhile GSK says its vaccine is progressing at an ‘unprecedented rate’
 - 
      
        
      
      NewsEuropean commission looks for endocrine disruptor definition
Consultation seeks opinion on a scientific description for these chemicals to help inform existing regulation
 - 
      News
US ramps up rare diseases research
National Institutes of Health spends $29 million to study more than 200 rare diseases
 - 
      
        
      
      
     - 
      
        
      
      
     - 
      Business
EMA finalises trial transparency rules
Researcher access reinstated, but company redaction rights may cause issues
 - 
      Business
Actavis boosts antibiotics with Durata buyout
$820 million deal gives Actavis control of newly-approved intravenous antibiotic
 - 
      
        
      
      ResearchBRCA2 protein imaged for first time
Insights into DNA repair mechanism could pave the way for new cancer therapies
 - 
      
        
      
      ResearchTea tonic peps up tumour treatment
Green tea polyphenol makes ‘magic bullet’ cancer drug delivery even more powerful
 - 
      
        
      
      PodcastChemistry World podcast - October 2014
We speak to Jason Sello about the hunt for new antibiotics, and Monique Simmonds explains the chemical role of botanical gardens